Eagle Pharmaceuticals shares owned by Royce & Associates
Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by Royce & Associates
from 13F filings
Historical chart of Royce & Associates investment in Eagle Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Eagle Pharmaceuticals held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Eagle Pharmaceuticals by Royce & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $52k | 14k | 3.73 |
| 2024-06-30 | $77k | 14k | 5.60 |
| 2024-03-31 | $72k | 14k | 5.24 |
| 2023-09-30 | $797k | 51k | 15.77 |
| 2023-06-30 | $1.2M | 59k | 19.44 |
| 2023-03-31 | $1.4M | 48k | 28.36 |
| 2022-12-31 | $1.0M | 35k | 29.24 |
| 2022-09-30 | $631k | 24k | 26.43 |
| 2022-06-30 | $1.4M | 30k | 44.44 |
| 2022-03-31 | $1.8M | 37k | 49.48 |
| 2021-12-31 | $949k | 19k | 50.90 |
| 2021-09-30 | $930k | 17k | 55.76 |
| 2021-06-30 | $676k | 16k | 42.79 |
| 2021-03-31 | $628k | 15k | 41.71 |
| 2020-12-31 | $589k | 13k | 46.55 |
| 2020-09-30 | $540k | 13k | 42.46 |
| 2020-06-30 | $1.8M | 38k | 47.98 |
| 2020-03-31 | $2.4M | 52k | 46.00 |
| 2019-12-31 | $3.0M | 50k | 60.08 |
| 2019-09-30 | $3.3M | 59k | 56.56 |
| 2019-06-30 | $3.8M | 68k | 55.68 |
| 2019-03-31 | $3.3M | 65k | 50.49 |
| 2018-12-31 | $1.5M | 37k | 40.28 |
| 2018-09-30 | $2.8M | 41k | 69.33 |
| 2018-06-30 | $3.0M | 40k | 75.65 |
| 2018-03-31 | $3.7M | 70k | 52.70 |
| 2017-12-31 | $4.9M | 91k | 53.42 |
| 2017-09-30 | $4.1M | 68k | 59.65 |